First Allied Advisory Services’s ARK Genomic Revolution ETF ARKG Stock Holding History

First Allied Advisory Services’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$2.04M	Buy	+32,062	New	+$1.88M	0.07%	290
2019 Q4	–	Sell	-800	Closed	-$24K	–	1218
2019 Q3	$24K	Buy	+800	New	+$26K	﹤0.01%	1444

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

MCM

Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CFA

Carroll Financial Associates Charlotte, North Carolina $1.88B AUM 20.52% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

CAN

Claraphi Advisory Network Aliso Viejo, United States $251M AUM 9.29% 1-Year Est. Return

First Allied Advisory Services's ARKG Position: Q3 2020 in Review

First Allied Advisory Services opened a new position in ARK Genomic Revolution ETF (ARKG) in Q3 2020: 32,062 shares worth $2.04M. The stake represents 0.07% of the portfolio and ranks #290 among its holdings. This is a return to the name: First Allied Advisory Services previously reported a position in ARKG as recently as Q3 2019.

First Allied Advisory Services first reported a position in ARKG in Q3 2019 and has held it in 2 quarters since. 243 funds tracked by Wall St. Rank hold ARKG as of Q3 2020.

First Allied Advisory Services held 32,062 shares of ARK Genomic Revolution ETF worth $2.04M as of Q3 2020.
ARK Genomic Revolution ETF was a new First Allied Advisory Services position in Q3 2020.
ARK Genomic Revolution ETF made up 0.07% of First Allied Advisory Services's portfolio in Q3 2020, its #290 holding.
First Allied Advisory Services first reported a position in ARK Genomic Revolution ETF in Q3 2019 and has held it in 2 quarters since.
243 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2020.

Based on First Allied Advisory Services's 13F filing for Q3 2020, filed 13 Nov 2020.